Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc.
  • Home
  • Our Coordinated Expression
    • Overview
    • Our Culture, Mission & Values
    • Our Commitment to Diversity, Equity & Inclusion
    • Message from BIO
  • Our People
    • Overview
    • Leadership
    • Board of Directors
  • Programs
    • Overview
    • Tamibarotene
    • SY-2101
    • SY-5609
    • Expanded Access Policy
  • Clinical Trials
  • Platform
    • Overview
    • What is Gene Control?
    • Publications and Abstracts
  • Patients
  • Investors & Media
  • Partners
  • Careers
  • Blog
  • Contact
Investors & Media

Investors & Media

  • Overview
  • News
    • Email Alerts
    • Press Releases
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Company Info
    • Fact Sheet
    • Profile
    • Leadership
    • Contacts
    • Analyst Coverage
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Annual Reports
    • IRS Tax Form 8937
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Filings
    • Quarterly Reports
    • Proxy
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor & Media Tools
    • Email Alerts
    • Fact Sheet
    • Tear Sheet
    • Contacts
    • RSS News Feed

IR Calendar

  • Events & Presentations

  • IR Calendar
  • Presentations

Syros Third Quarter 2021 Financial Results Conference Call

Nov 5, 2021 • 8:30am EDT

Webcast

Related Documents

3 2021
Quarter Results

PDF HTML
Release
Audio
Earnings Webcast
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
© 2023 Syros Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap
twitter logo linkedin logo